• The AACR Cancer Progress Report 2011 makes the case for boosting funding for the National Institutes of Health and the National Cancer Institute with annual budget increases at least 5% above the biomedical research inflation rate. The report can be downloaded at http://cancerprogressreport.org.

• Worldwide, the number of reported breast cancer cases has risen by 3.1% annually since 1980, while the incidence of cervical cancer has edged up by 0.6% a year, says a study from the Institute for Health Metrics and Evaluation. Developing countries are experiencing the majority of breast and cervical cancer occurrences, and higher mortality rates than developed countries.

• Donations are targeting tailored cancer treatments. The Johns Hopkins Kimmel Cancer Center received a $30 million donation from the Commonwealth Foundation for Cancer Research to establish a center for personalized cancer care. Former Genzyme chief executive Henri A. Termeer contributed a$10 million gift to Massachusetts General Hospital for the creation of a targeted cancer therapies center.

• The Food and Drug Administration has restructured its oncology division to allow for a more disease-specific approach. The new Office of Hematology and Oncology Products aims to provide greater clarity about where applications for specific therapies will be handled.

• The U.S. allotted 5.5% of its health care funds to research in 2010, for a total of $140.5 billion, according to Research!America's latest report. This percentage has remained unchanged over the last 6 years. • The 2011 Lasker-Bloomberg Public Service Award went to the NIH Clinical Center, the world's largest clinical research hospital. About 1,500 clinical research studies are currently in progress at the Center. • As of 2009, 26 states have accumulated$4.1 million for breast cancer research from specialty license plates. Illinois generated more than \$7.4 million through its one-of-a-kind breast cancer lottery ticket.